Greg Lucier, John Maraganore, Susan Siegel, Thane Kreiner, Stephen Fodor, Fisher, BioImage, Sigma-Aldrich, Bruker, Farfield Group, Thermo, Applera, ABI, Serologicals, Nanogen, Affymetrix | GenomeWeb

People

Invitrogen CEO Greg Lucier and Alnylam Pharmaceuticals President and Chief Executive Officer John Maraganore and have been appointed to the board of directors of the Biotechnology Industry Organization. Maraganore and Lucier will serve three-year terms.


Susan Siegel has resigned as president of Affymetrix, the company announced last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.